Next Article in Journal
Atopic Dermatitis: Sailing beyond the Sunset with a Multitude of Novel Treatments
Next Article in Special Issue
Practical Considerations for the Use of Cannabis in Cancer Pain Management—What a Medical Oncologist Should Know
Previous Article in Journal
Bridge Nodes between Personality Traits and Alcohol-Use Disorder Criteria: The Relevance of Externalizing Traits of Risk Taking, Callousness, and Irresponsibility
Previous Article in Special Issue
Fibromyalgia Syndrome and Cognitive Decline: The Role of Body Mass Index and Clinical Symptoms
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

Chronic Pain: Clinical Updates and Perspectives

by
Carmen M. Galvez-Sánchez
* and
Casandra I. Montoro
*
Department of Psychology, University of Jaén, 23071 Jaén, Spain
*
Authors to whom correspondence should be addressed.
J. Clin. Med. 2022, 11(12), 3474; https://doi.org/10.3390/jcm11123474
Submission received: 12 June 2022 / Accepted: 15 June 2022 / Published: 16 June 2022
(This article belongs to the Special Issue Chronic Pain: Clinical Updates and Perspectives)
The International Association for the Study of Pain (IASP) has defined pain as an unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage, which also comprises a subjective component [1]. Pain is characterized by a multidimensional nature in which three dimensions are usually differentiated: sensory-discriminative, emotional-affective, and cognitive-evaluative [1]. Furthermore, pain can be classified according to different aspects, for example the duration, the explaining cause, or the anatomical location [1]. Depending on the duration and the main classification, it is possible to differentiate between acute pain (less than 6 months) or chronic pain (more than 6 months) [1].
Regarding chronic pain, it entails a serious health burden, and a high comorbidity with other disorders such as anxiety, depression, insomnia, and cognitive impairments [2,3,4,5,6,7,8,9,10,11]. Given its high comorbidity with the above-reported disorders, chronic pain generates important socio-health expenses related to its management, as well as numerous indirect economic costs as a result of high rates of absenteeism, reduced labor productivity, and disability [12,13]. The prevalence of chronic pain in the general population of developing countries is estimated at 18% [14], and it is expected to increase with population growing and aging which in turn will require more effective prevention, diagnosis, and pain treatment strategies due to the higher associated socio-health and personal costs [15]. Chronic pain negatively affects both the patient and relatives’ quality of life [16,17]. Based on the aforementioned, chronic pain has been recognized as a bioethical issue [18] and different international organizations have declared the access to an adequate pain therapy as a human right [17,19,20].
The principal chronic pain disorders include headache, migraine, and local and generalized musculoskeletal diseases. The last may be further divided into those with inflammatory (i.e., autoimmune or infectious), mechanical (i.e., chronic low back pain), or unknown origin [21]. These disorders have in common the tendency to exhibit periods of remission of symptoms and phases of exacerbation [21].
Fibromyalgia, chronic tension-type headache, migraine, and the temporomandibular disorder are some examples of chronic pain disorders without a clear physiological cause. In all of these disorders, the pain intensity is found not to be proportional to the reported injury [22,23,24,25]. Nonetheless, the most empirically supported hypothesis is the presence of an alteration at central nervous system level [3,26]. The central pain processing mechanisms are proposed to be altered and produce a phenomenon called central sensitization. This phenomenon consists of a great sensitization to pain and excitability of the neurons of the posterior horns of the spinal cord and the reticulo-thalamic-cortical system [27,28]. Additionally, central sensitization implies a neuronal reorganization along with a deficient descending pain modulation system leading to an extreme sensitivity to touch, cold, or heat [29,30,31].
The intervention of chronic pain should be considered from a biopsychosocial perspective. As pointed out before, chronic pain is a condition characterized by physiological and biological correlates, in turn modulated by emotions (including negative beliefs) [4,32,33,34,35], personality factors [36,37,38,39,40], and coping styles [8,41], and related to different psychological behaviors [42]. In addition to these factors, the evolution and prognosis of chronic pain is not only affected by social but also by cultural factors (i.e., socio-economics, social support, educational level, work-related situation, etc.) [37,43]. Consequently, the treatment based on a multidisciplinary approach is shown to be the most effective in chronic pain management [44]. Anesthesiologists, psychiatrists, neurosurgeons, psychologists, and physiotherapists are frequently integrated into multidisciplinary pain teams [42]. Despite the benefits of the multidisciplinary approach in the treatment of chronic pain, it is not fully effective [45]. The treatment of chronic pain is still a current social and sanitary challenge [42], which also require personalized care to improve the health-related quality of the lives of these patients [46,47]. Personalized pain medicine remains a gap which needs to be overcome [48]. The person-centered medicine and personalized medicine in the areas of chronic pain research and management (including the cognitive, physical, affective, and behavioral domains) are necessary [46,49]. Authors point out the need for the fusion of these paradigms into a single new approach with the objective to avoid possible miscommunication, duplication of efforts, and ineffective treatment of chronic pain patients [47].
In general, to contribute to the effectiveness of chronic pain treatment, patients must be informed of the characteristics of the treatment. Thus, they are capable of committing to the treatment and can achieve better results [50]. It is crucial: (1) to establish clear and realistic therapeutic goals to motivate patients and increase their adherence to treatment, (2) to promote a good therapeutic alliance or rapport between the patient and the therapist, (3) to help patients to understand their responsibility in the treatment process, and (4) to ensure they are aware of the relevance of their implication to change the perspective from helplessness and despair to self-efficacy and personal self-control over the disorder [49]. Indeed, the perception of control and self-efficacy are issues to be addressed in any of the chronic pain treatments, because patients usually perceive pain as something uncontrollable, which generates low self-efficacy and hopelessness [51]. By contrast, patients with a higher perception of self-efficacy tend to have less pain, negative emotions, and disability and react better to treatment [51,52]. Therefore, active coping strategies must be promoted. Other elements such as postural and sleep hygiene, a proper diet, and regular and adapted physical exercise are further necessary to include in chronic pain treatment [5,49,53]. In addition, the involvement of patients´ relatives is vital for the success of the intervention, and the reinforcement of new, healthier behaviors and lifestyles on patients [54].
In sum, the chronic pain field requires continuous research in order to improve its prevention, diagnosis, and treatment. Considering the worldwide incidence, and prevalence of chronic pain in developing countries [14], scientists, clinicians, and governments must move forward together to overcome the great treatment challenge that chronic pain entails. This will markedly contribute to improving the health-related quality of life of patients and relatives, as well as to decreasing its socio-economic costs.

Funding

This research received no external funding.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. International Association for the Study of Pain (IASP). Pain IASP Taxonomy. 2015. Available online: http://www.iasp-pain.org/Education/Content.aspx?ItemNumber=1698&navItemNumber=576 (accessed on 12 May 2022).
  2. Montoro, C.I.; Duschek, S.; Muñoz Ladrón de Guevara, C.; Fernández-Serrano, M.J.; Reyes del Paso, G.A. Aberrant cerebral blood flow responses during cognition: Implications for the understanding of cognitive deficits in fibromyalgia. Neuropsychology 2015, 29, 173. [Google Scholar] [CrossRef]
  3. Montoro, C.I.; Duschek, S.; de Guevara, C.M.L.; Reyes del Paso, G.A. Patterns of cerebral blood flow modulation during painful stimulation in fibromyalgia: A transcranial doppler sonography study. Pain Med. 2016, 17, 2256–2267. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Amaro-Díaz, L.; Montoro, C.I.; Fischer-Jbali, L.R.; Galvez-Sánchez, C.M. Chronic Pain and Emotional Stroop: A Systematic Review. J. Clin. Med. 2022, 11, 3259. [Google Scholar] [CrossRef]
  5. Veehof, M.M.; Oskam, M.J.; Schreurs, K.M.; Bohlmeije, E.T. Acceptance-based interventions for the treatment of chronic pain: A systematic review and meta-analysis. Pain 2011, 152, 533–542. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  6. Galvez-Sánchez, C.M.; de la Coba, P.; Colmenero, J.M.; Reyes Del Paso, G.A.; Duschek, S. Attentional function in fibromyalgia and rheumatoid arthritis. PLoS ONE 2021, 16, e0246128. [Google Scholar] [CrossRef]
  7. Galvez-Sánchez, C.M.; Montoro, C.I.; Duschek, S.; Reyes Del Paso, G.A. Depression and trait-anxiety mediate the influence of clinical pain on health-related quality of life in fibromyalgia. J. Affect Disord. 2020, 265, 486–495. [Google Scholar] [CrossRef] [PubMed]
  8. Galvez-Sánchez, C.M.; Montoro, C.I.; Duschek, S.; Del Paso, G. Pain catastrophizing mediates the negative influence of pain and trait-anxiety on health-related quality of life in fibromyalgia. Qual. Life Res. 2020, 29, 1871–1881. [Google Scholar] [CrossRef]
  9. Galvez-Sánchez, C.M.; Reyes Del Paso, G.A.; Duschek, S. Cognitive Impairments in Fibromyalgia Syndrome: Associations with Positive and Negative Affect, Alexithymia, Pain Catastrophizing and Self-Esteem. Front. Psychol. 2018, 9, 377. [Google Scholar] [CrossRef] [Green Version]
  10. Galvez-Sánchez, C.M.; Muñoz Ladrón de Guevara, C.; Montoro, C.I.; Fernández-Serrano, M.J.; Duschek, S.; Reyes Del Paso, G.A. Cognitive deficits in fibromyalgia syndrome are associated with pain responses to low intensity pressure stimulation. PLoS ONE 2018, 13, e0201488. [Google Scholar] [CrossRef]
  11. Reyes del Paso, G.A.; Montoro, C.I.; Duschek, S. Reaction time, cerebral blood flow, and heart rate responses in fibromyalgia: Evidence of alterations in attentional control. J. Clin. Exp. Neuropsychol. 2015, 37, 414–428. [Google Scholar] [CrossRef]
  12. Societal Impact of Pain (SIP). Policy Recommendations 207. 2017. Available online: https://www.sip-platform.eu/resources/details/SIP_2017_Policy_Recommendations (accessed on 12 May 2022).
  13. Patel, A.S.; Farquharson, R.; Carroll, D.; Moore, A.; Phillips, C.J.; Taylor, R.S.; Barden, J. The impact and burden of chronic pain in the workplace: A qualitative systematic review. Pain Pract. 2012, 12, 578–589. [Google Scholar] [CrossRef] [PubMed]
  14. Sá, K.N.; Moreira, L.; Baptista, A.F.; Yeng, L.T.; Teixeira, M.J.; Galhardoni, R.; de Andrade, D.C. Prevalence of chronic pain in developing countries: Systematic review and meta-analysis. Pain Rep. 2019, 4, e779. [Google Scholar] [CrossRef] [PubMed]
  15. Breivik, H.; Collett, B.; Ventafridda, V.; Cohen, R.; Gallacher, D. Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment. Eur. J. Pain 2006, 10, 287–333. [Google Scholar] [CrossRef] [PubMed]
  16. Pereira, M.G.; Carvalho, C.; Costa, E.; Leite, Â.; Almeida, V. Quality of life in chronic pain patients: Illness- and wellness-focused coping as moderators. PsyCh J. 2021, 10, 283–294. [Google Scholar] [CrossRef] [PubMed]
  17. Domenichiello, A.F.; Ramsden, C.E. The silent epidemic of chronic pain in older adults. Prog. Neuropsychopharmacol. Biol. Psychiatry 2019, 93, 284–290. [Google Scholar] [CrossRef] [PubMed]
  18. Christopher, M.J. It’s time for bioethics to see chronic pain as an ethical issue. Am. J. Bioeth. 2011, 11, 3–4. [Google Scholar] [CrossRef]
  19. World Medical Association (WMA). WMA Resolution on the Access to Adequate Pain Treatment, Adopted by the 62nd WMA General Assembly, Montevideo, Uruguay. 2011. Available online: https://www.wma.net/policies-post/wma-resolution-on-the-access-to-adequate-pain-treatment/ (accessed on 12 May 2022).
  20. International Pain Summit of The International Association for The Study of Pain (IASP). Declaration of Montréal: Declaration that access to pain management is a fundamental human right. J. Pain Palliat. Care Pharmacother. 2011, 25, 29–31. [Google Scholar] [CrossRef]
  21. Breivik, H.; Eisenberg, E.; O’Brien, T. The individual and societal burden of chronic pain in Europe: The case for strategic prioritization and action to improve knowledge and availability of appropriate care. BMC Public Health 2013, 13, 1229–1243. [Google Scholar] [CrossRef] [Green Version]
  22. Yunus, M.B. Central sensitivity syndromes: An overview. J. Musculoskelet. Pain 2009, 17, 400–408. [Google Scholar] [CrossRef]
  23. Cernuda-Morollón, E.; Larrosa, D.; Ramón, C.; Vega, J.; Martínez-Camblor, P.; Pascual, J. Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine. Neurology 2013, 81, 1191–1196. [Google Scholar] [CrossRef]
  24. Yu, S.; Han, X. Update of chronic tension-type headache. Curr. Pain Headache Rep. 2015, 19, 469. [Google Scholar] [CrossRef] [PubMed]
  25. Sarlani, E.; Greenspan, J. Evidence for generalized hyperalgesia in temporo-mandibular disorders patients. Pain 2003, 10, 221–226. [Google Scholar] [CrossRef]
  26. Clauw, D.J. Fibromyalgia: A clinical review. JAMA 2014, 311, 1547–1555. [Google Scholar] [CrossRef] [PubMed]
  27. Latremoliere, A.; Woolf, C.J. Central sensitization: A generator of pain hypersensitivity by central neural plasticity. J. Pain 2009, 10, 895–926. [Google Scholar] [CrossRef] [Green Version]
  28. Kindler, L.L.; Bennett, R.M.; Jones, K.D. Central sensitivity syndromes: Mounting pathophysiologic evidence to link fibromyalgia with other common chronic pain disorders. Pain Manag. Nurs. 2011, 12, 15–24. [Google Scholar] [CrossRef] [Green Version]
  29. Woolf, C.J.; Salter, M.W. Neuronal plasticity: Increasing the gain in pain. Science 2000, 288, 1765–1768. [Google Scholar] [CrossRef]
  30. Woolf, C.J. Central sensitization: Implications for the diagnosis and treatment of pain. Pain 2011, 152, S2–S15. [Google Scholar] [CrossRef]
  31. De la Coba, P.; Montoro, C.I.; Reyes Del Paso, G.A.; Galvez-Sánchez, C.M. Algometry for the assessment of central sensitisation to pain in fibromyalgia patients: A systematic review. Ann. Med. 2022, 54, 1403–1422. [Google Scholar] [CrossRef]
  32. Montoro, C.I.; Duschek, S.; Schuepbach, D.; Gandarillas, M.; Reyes del Paso, G.A. Cerebral blood flow variability in fibromyalgia syndrome: Relationships with emotional, clinical and functional variables. PLoS ONE 2018, 13, e0204267. [Google Scholar] [CrossRef]
  33. Fischer-Jbali, L.R.; Montoro, C.I.; Montoya, P.; Halder, W.; Duschek, S. Central nervous activity during an emotional Stroop task in fibromyalgia syndrome. Int. J. Psychophysiol. 2022, 177, 133–144. [Google Scholar] [CrossRef]
  34. Fischer-Jbali, L.R.; Montoro, C.I.; Montoya, P.; Halder, W.; Duschek, S. Central nervous activity during implicit processing of emotional face expressions in fibromyalgia syndrome. Brain Res. 2021, 1758, 147333. [Google Scholar] [CrossRef]
  35. Fischer-Jbali, L.R.; Montoro, C.I.; Montoya, P.; Halder, W.; Duschek, S. Central Nervous Activity during a Dot Probe Task with Facial Expressions in Fibromyalgia. Biol. Psychol. 2021, 108361. [Google Scholar] [CrossRef] [PubMed]
  36. Montoro, C.I.; del Paso, G.A.R. Personality and fibromyalgia: Relationships with clinical, emotional, and functional variables. Pers. Individ. Differ. 2015, 85, 236–244. [Google Scholar] [CrossRef]
  37. Galvez-Sánchez, C.M.; Duschek, S.; Reyes Del Paso, G.A. Psychological impact of fibromyalgia: Current perspectives. Psychol. Res. Behav. Manag. 2019, 12, 117–127. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  38. Galvez-Sánchez, C.M.; Reyes Del Paso, G.A.; Duschek, S.; Montoro, C.I. The Link between Fibromyalgia Syndrome and Anger: A Systematic Review Revealing Research Gaps. J. Clin. Med. 2022, 11, 844. [Google Scholar] [CrossRef]
  39. Galvez-Sánchez, C.M.; Montoro Aguilar, C.I. Migraine and Neuroticism: A Scoping Review. Behav. Sci. 2022, 12, 30. [Google Scholar] [CrossRef]
  40. Montoro Aguilar, C.I.; Duschek, S.; Reyes del Paso, G.A. An exploratory analysis of the influence of personality and emotional factors on cerebral blood flow responses during painful stimulation in fibromyalgia. Scand. J. Psychol. 2018, 59, 301–310. [Google Scholar] [CrossRef]
  41. Montoro, C.I.; Reyes del Paso, G.A.; Duschek, S. Alexithymia in fibromyalgia syndrome. Pers. Individ. Differ. 2016, 102, 170–179. [Google Scholar] [CrossRef]
  42. Kanner, R. Secretos En El Tratamiento Del Dolor; McGraw-Hill Interamericana: Mexico City, Mexico, 2006. [Google Scholar]
  43. Duschek, S.; Nassauer, L.; Montoro, C.I.; Bair, A.; Montoya, P. Dispositional empathy is associated with experimental pain reduction during provision of social support by romantic partners. Scand. J. Pain 2019, 20, 205–209. [Google Scholar] [CrossRef]
  44. Warfield, C.A.; Fausett, H.J. Manual De Diagnóstico y De Tratamiento Del Dolor; Masson: Barcelona, Spain, 2004. [Google Scholar]
  45. Siracusa, R.; Paola, R.D.; Cuzzocrea, S.; Impellizzeri, D. Fibromyalgia: Pathogenesis, Mechanisms, Diagnosis and Treatment Options Update. Int. J. Mol. Sci. 2021, 22, 3891. [Google Scholar] [CrossRef]
  46. Davydov, D.M.; Galvez-Sánchez, C.M.; Montoro, C.I.; de Guevara, C.; Reyes Del Paso, G.A. Personalized behavior management as a replacement for medications for pain control and mood regulation. Sci. Rep. 2021, 11, 20297. [Google Scholar] [CrossRef] [PubMed]
  47. Braš, M.; Dorđević, V.; Milunović, V.; Brajković, L.; Miličić, D.; Konopka, L. Person-centered medicine versus personalized medicine: Is it just a sophism? A view from chronic pain management. Psychiatr. Danub. 2011, 23, 246–250. [Google Scholar] [PubMed]
  48. Bruehl, S. Personalized pain medicine: Pipe dream or reality? Anesthesiology 2015, 122, 967–968. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  49. Muñoz Ladrón de Guevara, C.; Reyes del Paso, G.A.; Fernández Serrano, M.J.; Montoro, C.I. Fibromyalgia Syndrome and Cognitive Decline: The Role of Body Mass Index and Clinical Symptoms. J. Clin. Med. 2022, 11, 3404. [Google Scholar] [CrossRef]
  50. Galvez-Sánchez, C.M.; Montoro, C.I.; Moreno-Padilla, M.; Reyes Del Paso, G.A.; de la Coba, P. Effectiveness of Acceptance and Commitment Therapy in Central Pain Sensitization Syndromes: A Systematic Review. J. Clin. Med. 2021, 10, 2706. [Google Scholar] [CrossRef]
  51. Mirsharifa, S.M.; Mirzaian, B.; Dousti, Y. The efficacy of Acceptance and Commitment Therapy (ACT) Matrix on depression and psychological capital of the patients with irritable bowel syndrome. Open Access Maced. J. Med. Sci. 2019, 7, 421. [Google Scholar] [CrossRef] [Green Version]
  52. Wicksell, R.K.; Kemani, M.; Jensen, K.; Kosek, E.; Kadetoff, D.; Sorjonen, K.; Ingvar, M.; Olsson, G.L. Acceptance and commitment therapy for fibromyalgia: A randomized controlled trial. Eur. J. Pain 2013, 17, 599–611. [Google Scholar] [CrossRef]
  53. Otis, J.D. Managing Chronic Pain. A Cognitive-Behavioral Therapy Approach; Oxford University Press: New York, NY, USA, 2007. [Google Scholar]
  54. Cooper, S.; Gilbert, L. The role of ‘social support’ in the experience of fibromyalgia—Narratives from South Africa. Health Soc. Care Community 2017, 25, 1021–1030. [Google Scholar] [CrossRef]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Galvez-Sánchez, C.M.; Montoro, C.I. Chronic Pain: Clinical Updates and Perspectives. J. Clin. Med. 2022, 11, 3474. https://doi.org/10.3390/jcm11123474

AMA Style

Galvez-Sánchez CM, Montoro CI. Chronic Pain: Clinical Updates and Perspectives. Journal of Clinical Medicine. 2022; 11(12):3474. https://doi.org/10.3390/jcm11123474

Chicago/Turabian Style

Galvez-Sánchez, Carmen M., and Casandra I. Montoro. 2022. "Chronic Pain: Clinical Updates and Perspectives" Journal of Clinical Medicine 11, no. 12: 3474. https://doi.org/10.3390/jcm11123474

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop